Sharps Technology Retained Earnings (Accumulated Deficit) 2022-2024 | STSS

Sharps Technology retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Sharps Technology Retained Earnings (Accumulated Deficit) 2022-2024 | STSS

Sharps Technology retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$195.6B
Stryker (SYK)$137.3B
Boston Scientific (BSX)$122.7B
Medtronic (MDT)$114.6B
EssilorLuxottica (ESLOY)$108.8B
Haleon (HLN)$48.7B
Lonza Group Ag (LZAGY)$46B
ResMed (RMD)$35.1B
Koninklijke Philips (PHG)$30.8B
Terumo (TRUMY)$28.5B
Zimmer Biomet Holdings (ZBH)$22B
Baxter (BAX)$19.9B
Insulet (PODD)$16.3B
Smith & Nephew SNATS (SNN)$13.6B
Bio-Rad Laboratories (BIO)$9.2B
Demant (WILYY)$8.7B
BellRing Brands (BRBR)$7.9B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.3B
Haemonetics (HAE)$4.1B
TG Therapeutics (TGTX)$3.7B
Neogen (NEOG)$3.6B
Prestige Consumer Healthcare (PBH)$3.5B
GN Store Nord (GNNDY)$3.5B
Perrigo (PRGO)$3.5B
Envista Holdings (NVST)$3.4B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Green Thumb Industries (GTBIF)$2.2B
Maravai LifeSciences Holdings (MRVI)$2.1B